Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody

Cancer Immunology Immunotherapy

Volumn 48, Issue 5, 1999, Pages 230-238

  Rice, David C ^a   Chapoval, Andrei I ^a   Porter, Louis ^a   Nelson, Heidi ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bispecific antibodies; Immunotherapy; Superantigens; T lymphocyte; Tumor immunity

Indexed keywords

ANTINEOPLASTIC AGENT; BISPECIFIC ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY CD3; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENCY; FEMALE; LUNG CARCINOGENESIS; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, NEOPLASM; ANTIGENS, CD4; ANTIGENS, CD8; ENTEROTOXINS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNIZATION, PASSIVE; IMMUNOLOGIC MEMORY; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MELANOMA; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032796829     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050570     Document Type: Article

References (41)

1. 1. Bette M, Schafer MK, Rooijen N van, Weihe E, Fleischer B (1993) Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med 178:1531
2. 2. Bluestone JA, Bruce DS, and Newell KA (1992) Activation of T cells in vivo using anti-CD3 and staphylococcal enterotoxins (review). Int J Cancer [Suppl] 7:39
3. 3. Callahan JE, Herman A, Kappler JW, Marrack P (1990) Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J Immunol 144:2473
4. 2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes. J Immunol 155:1296
5. 5. Chapoval AI, Thibault C, Nelson H (1995) Anti-CD3 × antitumor bifunctional antibodies induce cytotoxicity in tumor infiltrating lymphocytes. In: The 9th International Congress of Immunology San Francisco, California 23-29 July 1995, p. 311
6. 6. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D (1990) Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115
7. 7. Demanet C, Brissinck J, Leo O, Moser M, Thielemans K (1994) Role of T-cell subsets in the bispecific antibody (anti-idiotype × anti-CD3) treatment of the BCL1 lymphoma. Cancer Res 54:2973
8. 8. Garrido MA, Perez P, Titus JA, et al (1990) Targeted cytotoxic cells in human peripheral blood lymphocytes. J Immunol 144:2891
9. + T lymphocytes to a B cell lymphoma. A comparison of anti-CD3-anti-idiotype antibody conjugates and antigen-anti-idiotype antibody conjugates. J Immunol 142:4079
10. 10. Jung G, Martin DE, Muller-Eberhard HJ (1987) Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3. J Immunol 139:639
11. 11. Krakauer T (1995) Differential inhibitory effects of interleukin-10, interleukin-4, and dexamethasone on staphylococcal enterotoxin-induced cytokine production and T cell activation. J Leukoc Biol 57:450
12. 12. Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET (1995) T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities. J Immunol 154:3969
13. 13. Lau LL, Jamieson BD, Somasundaram T, Ahmed R (1994) Cytotoxic T-cell memory without antigen (see comments). Nature 369:648
14. 14. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA (1987) Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84:1374
15. 15. Livingston PO, Wong GY, Adluri S, et al (1994) Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglio-side. J Clin Oncol 12:1036
16. 16. McAdam AJ, Pulaski BA, Harkins SS, Hutter EK, Lord EM, Frelinger JG (1995) Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. Int J Cancer 61:628
17. 17. McAveney KM, Gomella LG, Lattime EC (1994) Induction of TH1-and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy. Cancer Immunol Immunother 39:401
18. 2 antibody prolong host survival in a murine xenograft model. Cancer Res 51:5716
19. 19. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, (review). Annu Rev Immunol 7:145
20. 20. Mule JJ, Yang JC, Afreniere RL, Shu SY, Rosenberg SA (1987) Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol 139:285
21. 21. Mullbacher A (1994) The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 179:317
22. 22. Nelson H, McKean DJ, Kerr LA, Donohue JH (1990) Anti-tumor × anti-CD3 heteroconjugates direct human peripheral blood lymphocytes to lyse colon tumor cells. J Surg Res 48: 284
23. 23. Newell KA, Ellenhorn JD, Bruce DS, Bluestone JA (1991) In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci USA 88:1074
24. 24. Nishimura T, Nakamura Y, Tsukamoto H, et al (1992) Human c-erbB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy. Int J Cancer 50:800
25. 25. Nitta T, Sato K, Yagita H, Okumura K, Ishii S (1990) Preliminary trial of specific targeting therapy against malignant glioma. Science 248:1066
26. 26. Parham P (1983) On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol 131:2895
27. 27. Penna C, Dean PA, Nelson H (1994) Antitumor × anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res 54:2738
28. 28. Plaksin D, Porgador A, Vadai E, Feldman M, Schirrmacher V, Eisenbach L (1994) Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV). Int J Cancer 59:796
29. 29. Porter LE, Nelson H, Ethem Gecim I, Rice DC, Thibault C, Chapoval AI (1997) T cell activation and retargeting using staphylococcal enterotoxin B and bispecific antibody: an effective in vivo antitumor strategy. Cancer Immunol Immunother 45:180
30. 30. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group (see comments). Lancet 343:1177
31. 31. Romani L, Puccetti P, Mencacci A, Spaccapelo R, Cenci E, Tonnetti L, Bistoni F (1994) Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans. Infect Immun 62:4047
32. 32. Rosenberg SA, Lotze MT, Muul LM, et al (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889
33. 33. Saleh MN, Khazaeli MB, Grizzle WE, et al (1993) A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer. Cancer Res 53:4555
34. 34. Segal DM, Qian JH, Titus JA, et al (1992) Targeted cytokine production (review). Int J Cancer (Suppl) 7:36
35. 35. Shu S, Sussman JJ, Chang AE (1993) In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagents. J Immunother 14:279
36. 36. Shu S, Krinock RA, Matsumura T, Sussman JJ, Fox BA, Chang AE, Terman DS (1994) Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. J Immunol 152:1277
37. 2 bispecific antibodies. Int J Cancer 67:232
38. 38. Valone FH, Kaufman PA, Guyre PM, et al (1995) Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol 13:2281
39. 39. Weiner GJ, Kostelny SA, Hillstrom JR, Cole MS, Link BK, Wang SL, Tso JY (1994) The role of T cell activation in anti-CD3 × antitumor bispecific antibody therapy. J Immunol 152:2385
40. 40. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P (1989) The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27
41. 41. Woodbury RG, Brown JP, Yeh MY, Hellstrom I, Hellstrom KE (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 77:2183